Condition
Cancer
Estimated Enrollment: 75
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: 010124|01-C-0124|NCI-2792|CDR0000068615
Study First Received: July 11, 2001
Last Updated: March 14, 2012
Estimated Primary Completion Date: April 2008
Primary Outcome Measures:
Dose-limiting toxicities and maximum tolerated dose|Pharmacology and pharmacokinetics|Acetylation of histones in peripheral blood|Tumor response by CT scan every 12 weeks
Sponsors and Collaborators:
National Institutes of Health Clinical Center (CC)|National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT00020579
